Dataset Information
Cost-effectiveness analysis of datopotamab deruxtecan versus docetaxel for previously treated advanced or metastatic non-small cell lung cancer.
Ontology highlight
ABSTRACT:
SUBMITTER: Zeng F
PROVIDER: S-EPMC12752073 | biostudies-literature | 2025 Dec
REPOSITORIES: biostudies-literature